MAPT and depressive symptom measurement: Though no previously published studies have investigated the relationship between tau pathology captured with functional neuroimaging and AD psychosis, previous studies have associated increased tau PET ligand retention with psychosis in other conditions such as late-life depression [42], and psychosis in traumatic brain injury [43].